Z Gordon Jiang1, Ian H de Boer2, Rachel H Mackey3, Majken K Jensen4, Michelle Lai5, Simon C Robson5, Russell Tracy6, Lewis H Kuller7, Kenneth J Mukamal8. 1. Division of Gastroenterology and Hepatology, Department of Medicine, Beth Israel Deaconess Medical Center, Harvard School of Medicine, Boston, MA 02115. Electronic address: zgjiang@bidmc.harvard.edu. 2. Division of Nephrology, University of Washington, Seattle, WA 98195. 3. Department of Pathology, University of Vermont College of Medicine, Burlington, VT 05405. 4. Department of Nutrition, Harvard School of Public Health, Boston, MA 02115. 5. Division of Gastroenterology and Hepatology, Department of Medicine, Beth Israel Deaconess Medical Center, Harvard School of Medicine, Boston, MA 02115. 6. Department of Pathology and Laboratory Medicine, University of Vermont College of Medicine, Burlington, VT 05405. 7. Department of Epidemiology, University of Pittsburgh Graduate School of Public Health, Pittsburgh, PA 15261. 8. Division of General Medicine and Primary Care, Beth Israel Deaconess Medical Center, Boston, MA 02115.
Abstract
INTRODUCTION: Production of very low-density lipoprotein (VLDL) is increased in states of metabolic syndrome, leading to hypertriglyceridemia. However, metabolic syndrome is often associated with non-alcoholic fatty liver disease, which leads to liver fibrosis and inflammation that may decrease VLDL production. In this study, we aim to determine the interactive impact on VLDL profiles from insulin resistance, impairment in liver synthetic function and inflammation. METHODS: We examined cross-sectional associations of insulin sensitivity, inflammation, and liver synthetic function with VLDL particle (VLDL-P) concentration and size among 1,850 older adults in the Cardiovascular Health Study. RESULTS: Indices for high insulin sensitivity and low liver synthetic function were associated with lower concentrations of VLDL-P. In addition, insulin resistance preferentially increased concentration of large VLDL and was associated with mean VLDL size. Indices for inflammation however demonstrated a nonlinear relationship with both VLDL-P concentration and VLDL size. When mutually adjusted, one standard deviation (SD) increment in Matsuda index and C-reactive protein (CRP) were associated with 4.9 nmol/L (-8.2 to -1.5, p=0.005) and 6.3 nmol/L (-11.0 to -1.6, p=0.009) lower VLDL-P concentration respectively. In contrast, one-SD increment in factor VII, a marker for liver synthetic function, was associated with 16.9 nmol/L (12.6-21.2, p<0.001) higher VLDL-P concentration. Furthermore, a one-SD increment in the Matsuda index was associated with 1.1 nm (-2.0 to -0.3, p=0.006) smaller mean VLDL size, whereas CRP and factor VII were not associated with VLDL size. CONCLUSION: Insulin sensitivity, inflammation and markers for liver synthetic function differentially impact VLDL-P concentration and VLDL size. These results underscore the complex effects of insulin resistance and its complications on VLDL production.
INTRODUCTION: Production of very low-density lipoprotein (VLDL) is increased in states of metabolic syndrome, leading to hypertriglyceridemia. However, metabolic syndrome is often associated with non-alcoholic fatty liver disease, which leads to liver fibrosis and inflammation that may decrease VLDL production. In this study, we aim to determine the interactive impact on VLDL profiles from insulin resistance, impairment in liver synthetic function and inflammation. METHODS: We examined cross-sectional associations of insulin sensitivity, inflammation, and liver synthetic function with VLDL particle (VLDL-P) concentration and size among 1,850 older adults in the Cardiovascular Health Study. RESULTS: Indices for high insulin sensitivity and low liver synthetic function were associated with lower concentrations of VLDL-P. In addition, insulin resistance preferentially increased concentration of large VLDL and was associated with mean VLDL size. Indices for inflammation however demonstrated a nonlinear relationship with both VLDL-P concentration and VLDL size. When mutually adjusted, one standard deviation (SD) increment in Matsuda index and C-reactive protein (CRP) were associated with 4.9 nmol/L (-8.2 to -1.5, p=0.005) and 6.3 nmol/L (-11.0 to -1.6, p=0.009) lower VLDL-P concentration respectively. In contrast, one-SD increment in factor VII, a marker for liver synthetic function, was associated with 16.9 nmol/L (12.6-21.2, p<0.001) higher VLDL-P concentration. Furthermore, a one-SD increment in the Matsuda index was associated with 1.1 nm (-2.0 to -0.3, p=0.006) smaller mean VLDL size, whereas CRP and factor VII were not associated with VLDL size. CONCLUSION:Insulin sensitivity, inflammation and markers for liver synthetic function differentially impact VLDL-P concentration and VLDL size. These results underscore the complex effects of insulin resistance and its complications on VLDL production.
Authors: L P Fried; N O Borhani; P Enright; C D Furberg; J M Gardin; R A Kronmal; L H Kuller; T A Manolio; M B Mittelmark; A Newman Journal: Ann Epidemiol Date: 1991-02 Impact factor: 3.797
Authors: Lewis Kuller; Alice Arnold; Russell Tracy; James Otvos; Greg Burke; Bruce Psaty; David Siscovick; David S Freedman; Richard Kronmal Journal: Arterioscler Thromb Vasc Biol Date: 2002-07-01 Impact factor: 8.311
Authors: Päivi Hämäläinen; Juha Saltevo; Hannu Kautiainen; Pekka Mäntyselkä; Mauno Vanhala Journal: Lipids Health Dis Date: 2018-01-10 Impact factor: 3.876
Authors: Timo Paavola; Sanna Kuusisto; Matti Jauhiainen; Sakari Kakko; Tiia Kangas-Kontio; Jari Metso; Pasi Soininen; Mika Ala-Korpela; Risto Bloigu; Minna L Hannuksela; Markku J Savolainen; Tuire Salonurmi Journal: PLoS One Date: 2017-02-16 Impact factor: 3.240
Authors: Bridget A Hannon; Sharon V Thompson; Caitlyn G Edwards; Sarah K Skinner; Grace M Niemiro; Nicholas A Burd; Hannah D Holscher; Margarita Teran-Garcia; Naiman A Khan Journal: Curr Dev Nutr Date: 2018-11-28
Authors: Olubunmi O Olubamwo; Jyrki K Virtanen; Jussi Pihlajamaki; Pekka Mantyselka; Tomi-Pekka Tuomainen Journal: BMJ Open Date: 2019-09-05 Impact factor: 2.692